Cargando…
Broad Spectrum Antiangiogenic Treatment for Ocular Neovascular Diseases
Pathological neovascularization is a hallmark of late stage neovascular (wet) age-related macular degeneration (AMD) and the leading cause of blindness in people over the age of 50 in the western world. The treatments focus on suppression of choroidal neovascularization (CNV), while current approved...
Autores principales: | Benny, Ofra, Nakai, Kei, Yoshimura, Takeru, Bazinet, Lauren, Akula, James D., Nakao, Shintaro, Hafezi-Moghadam, Ali, Panigrahy, Dipak, Pakneshan, Pouya, D'Amato, Robert J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931703/ https://www.ncbi.nlm.nih.gov/pubmed/20824139 http://dx.doi.org/10.1371/journal.pone.0012515 |
Ejemplares similares
-
Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug
por: Yoshimura, Takeru, et al.
Publicado: (2013) -
Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
por: Verheul, H M W, et al.
Publicado: (1999) -
Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity
por: Sekiyama, Eiichi, et al.
Publicado: (2012) -
Antiangiogenic effects of catalpol on rat corneal neovascularization
por: Han, Yun, et al.
Publicado: (2018) -
Lymphatics and Lymphangiogenesis in the Eye
por: Nakao, Shintaro, et al.
Publicado: (2012)